ISSN: 2577-4328
Authors: YK Lahir
Cancerous condition is the result of abnormal physiological and cellular mechanisms that develop in an individual. The cells prone to cancer exhibit complexed behavioral abnormalities and disobedience to the normal cellular signaling pathways. Benign and malignant cancers show different proliferative behavior depending on the type of cells, their location, and functions. The cancerous tissues have increased vascular supply and a lower ratio of the rate of conversion of oxy-hemoglobin to deoxy-hemoglobin. In tissues, like the dense radiographic breast, show some morphological changes in the cell organelles like nuclei. The carbon nanoparticles act as suitable agents for carrying antiviral drugs, antibiotics, anticancer drugs, agents for imaging, and thermal ablation. Further, considering the multifaceted features, carbon nanomaterials can be a potential agent to induce apoptosis in the cancerous tissue that might help to restrict its growth. All these intentions need careful examinations, applications at laboratory, clinical, and mass-scale production, keeping in mind the environmental, judicial aspects, and human tendencies of maximizing their benefits. This short review is an effort to evaluate the potentials of carbon nanomaterials that can induce apoptosis in cancer tissue.
Keywords: Apoptosis; Biocompatibility; Biodistribution; Cancer Biomarkers; Cancerous Tissue; Carbon Nanomaterials
